NASDAQ : BFRG

Bullfrog AI Holdings, Inc. Common Stock

$0.6001 USD

$0.02 (3.47%)

Volume
68.12K
Average Volume
237.15K
Market Capitalization
$11.13M
P/E Ratio
-1.09
Dividend Yield
0.00%
Price Target
Year High
$2.04
Year Low
$0.43
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$8.15
Company Overview

NASDAQ

Vininder Singh

Medical - Healthcare Information Services

Healthcare

BFRG

9

US

USD

240 658 6710

12021E109

0001829247

Liquidity Metrics

0.03

8.15

8.15

7.79

0.00

Sales & Valuation

$116.67K

95.37

1.59

-2.05

-0.42

Profitability

-$0.63

-$6.5M

-5205.86%

-5205.86%

-217.79%

-109.66%

P/E Metrics

-1.09

-0.02

-0.02

Analyst Price Target & Rating

Sell

2/5

0 Analysts

%

Financial Health Scores

-2.43

3/9

$4.66M

$5.54M

$652.07K

-$6.07M

Key Metrics (TTM)

$1.82M

15.60

-0.30

8.15

-217.79%

-122.55%

-80.87%

-80.07%

-832 days

Company Executives
Name Title
J. T. Koffenberger Head of Information Technology
Antonio V. Montano Chief Marketing Officer & Growth Strategy Leader
Cetin Savkli Chief AI Advisor & Member of Advisory Board
Eric Roos SVP of Business Development & Corporate Strategy
John Stewart SVP of Commercial Sales
Joshua Blacher Chief Financial Officer
Vininder Singh Founder, Chairman & Chief Executive Officer
David Recker FACP FACR Chief Medical Officer
Praveen Kudithipudi Chief Business Development Officer
Poll Results

No votes yet today — be the first to share your view!

About Bullfrog AI Holdings, Inc. Common Stock (NASDAQ:BFRG) Stock

BullFrog AI Holdings, Inc., along with its affiliated entities, functions as an advanced digital biopharmaceutical firm. Its core mission involves harnessing artificial intelligence and machine learning (AI/ML) to process and interpret extensive medical and healthcare datasets specifically within the United States. A central offering is bfLEAP, a proprietary AI/ML platform meticulously crafted for the thorough examination of both preclinical and clinical research data. The company has also secured critical intellectual property through licensing agreements. One such accord, with George Washington University, provides rights to utilize siRNA targeting Beta2-spectrin. This technology is being investigated for its therapeutic potential across a spectrum of human conditions, including hepatoce ... llular carcinoma, obesity, non-alcoholic fatty liver disease (NAFLD), and non-alcoholic steatohepatitis (NASH). Additionally, a partnership with Johns Hopkins University grants access to a distinct Mebendazole formulation, developed for the treatment of various human cancers or neoplastic diseases. Founded in 2017, BullFrog AI Holdings, Inc. operates from its headquarters in Gaithersburg, Maryland.

BullFrog AI to Participate in the BTIG Virtual Biotechnology Conference

2026-07-22 16:15:00

GAITHERSBURG, Md., July 22, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), an AI company using three complementary capabilities to turn complex biomedical data into actionable insights, announces that the Company's management team will participate in the BTIG Virtual Biotechnology Conference being held on July 28-29, 2026.

BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026

2026-07-21 16:15:00

GAITHERSBURG, Md., July 21, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), an AI company using three complementary capabilities to turn complex biomedical data into actionable insights, announces that Vin Singh, Founder and Chief Executive Officer of BullFrog AI, will participate in the upcoming Water Tower Research Fireside Chat Series, taking place on Thursday, July 23, 2026 at 1:00 pm ET.

Water Tower Research Publishes Initiation of Coverage Report on BullFrog AI Holdings, Inc., "Helping Big Pharma Look Before It Leaps in Drug Discovery"

2026-06-24 13:00:00

June 24, 2026, ST. PETERSBURG, FL – Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on BullFrog AI Holdings, Inc. (NASDAQ: BFRG) titled, “Helping Big Pharma Look Before It Leaps in Drug Discovery”. The report can be accessed here. BullFrog AI Holdings, Inc. (NASDAQ: BFRG) is a Gaithersburg, Maryland-based AI company that is focused on the pharmaceutical R&D market. BullFrog uses AI to increase the success rate of drug development while reducing the time and investment it requires. The company commercializes a proprietary, end-to-end AI and ML platform that prepares biomedical data, identifies the biological drivers of disease, and supports development decisions. The platform targets a core inefficiency in drug development: bringing a new drug to market typically takes 10-15 years and $1-2 billion, and even then, roughly half of the drugs that reach Phase 3 still fail, often because developers picked the wrong target or could not identify which patients a drug actually helps.

BullFrog AI Announces New Commercial Leadership Team to Execute Growth Strategy for its Integrated Pharma AI Platform

2026-06-02 08:00:00

GAITHERSBURG, Md., June 02, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence (“AI”) and machine learning to turn complex biomedical data into actionable insights, today announced it has appointed commercial technology sales and scientific-focused leaders to support the momentum of the Company's commercial business driven growth strategy.

Frequently Asked Questions

What is the current Bullfrog AI Holdings, Inc. Common Stock (BFRG) stock price?

Bullfrog AI Holdings, Inc. Common Stock(NASDAQ:BFRG) stock price is $0.6001 in the last trading session. During the trading session, BFRG stock reached the peak price of $2.04 while $0.425 was the lowest point it dropped to. The percentage change in BFRG stock occurred in the recent session was 3.47% while the dollar amount for the price change in BFRG stock was $0.02.

BFRG's industry and sector of operation?

The NASDAQ listed BFRG is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector.

Who are the executives of BFRG?

J. T. Koffenberger | Head of Information Technology
Antonio V. Montano | Chief Marketing Officer & Growth Strategy Leader
Cetin Savkli | Chief AI Advisor & Member of Advisory Board
Eric Roos | SVP of Business Development & Corporate Strategy
John Stewart | SVP of Commercial Sales

How many employees does BFRG have?

Number of BFRG employees currently stands at 9. BFRG operates from 325 Ellington Blvd., Gaithersburg, MD 20878, US.

Link for BFRG official website?

Official Website of BFRG is: https://www.bullfrogai.com

How do I contact BFRG?

BFRG could be contacted at phone #240 658 6710 and can also be accessed through its website. BFRG operates from 325 Ellington Blvd., Gaithersburg, MD 20878, US.

How many shares of BFRG are traded daily?

The average number of BFRG shares traded daily for last 3 months was 237.15K.

What is the market cap of BFRG currently?

The market value of BFRG currently stands at $11.13M with its latest stock price at $0.6001